Even with the development and FDA approval in recent years of the first rapid-acting antidepressant medicines—to which more than 90 BBRF grants have contributed—the search for novel depression…
Read More
Researchers say they have identified an objective biomarker of recovery in major depression that in a small cohort of treatment-resistant patients was able (on an ongoing basis) to capture whether…
Read More
About 1.4% of U.S. adults (over 3 million people) experience Borderline Personality Disorder (BPD) in a typical year. But BPD is difficult to treat. Evidence for the effectiveness of medications…
Read More
In its first randomized, placebo-controlled test, an enhanced form of non-invasive brain stimulation called SNT (Stanford Neuromodulation Therapy, formerly called SAINT) generated "a large…
Read More
Over the past three years, researchers at The University of California, San Francisco (UCSF)—three of them BBRF grantees and one a member of BBRF’s Scientific Council—have published three papers that…
Read More
